PL3325080T3 - Sposoby lepszego dostarczania środków czynnych do guzów - Google Patents

Sposoby lepszego dostarczania środków czynnych do guzów

Info

Publication number
PL3325080T3
PL3325080T3 PL16831139T PL16831139T PL3325080T3 PL 3325080 T3 PL3325080 T3 PL 3325080T3 PL 16831139 T PL16831139 T PL 16831139T PL 16831139 T PL16831139 T PL 16831139T PL 3325080 T3 PL3325080 T3 PL 3325080T3
Authority
PL
Poland
Prior art keywords
tumors
ways
active agents
better delivery
delivery
Prior art date
Application number
PL16831139T
Other languages
English (en)
Inventor
Russell Frederick Ross
Original Assignee
Sorrento Therapeutics, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sorrento Therapeutics, Inc. filed Critical Sorrento Therapeutics, Inc.
Publication of PL3325080T3 publication Critical patent/PL3325080T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays or needleless injectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M2037/0007—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin having means for enhancing the permeation of substances through the epidermis, e.g. using suction or depression, electric or magnetic fields, sound waves or chemical agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0023—Drug applicators using microneedles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0038—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles having a channel at the side surface
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0061—Methods for using microneedles

Landscapes

  • Health & Medical Sciences (AREA)
  • Dermatology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Medical Informatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
PL16831139T 2015-07-24 2016-07-22 Sposoby lepszego dostarczania środków czynnych do guzów PL3325080T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201562196578P 2015-07-24 2015-07-24
US201562196570P 2015-07-24 2015-07-24
PCT/US2016/043623 WO2017019526A2 (en) 2015-07-24 2016-07-22 Methods for better delivery of active agents to tumors
EP16831139.7A EP3325080B1 (en) 2015-07-24 2016-07-22 Methods for better delivery of active agents to tumors

Publications (1)

Publication Number Publication Date
PL3325080T3 true PL3325080T3 (pl) 2022-01-24

Family

ID=57885141

Family Applications (1)

Application Number Title Priority Date Filing Date
PL16831139T PL3325080T3 (pl) 2015-07-24 2016-07-22 Sposoby lepszego dostarczania środków czynnych do guzów

Country Status (15)

Country Link
US (3) US10806913B2 (pl)
EP (2) EP3325080B1 (pl)
JP (1) JP7082041B2 (pl)
KR (1) KR20180035209A (pl)
CN (2) CN107921248A (pl)
AU (3) AU2016297823B2 (pl)
BR (1) BR112018001292A2 (pl)
CA (1) CA2991455C (pl)
DK (1) DK3325080T3 (pl)
ES (1) ES2891523T3 (pl)
HU (1) HUE056410T2 (pl)
MX (2) MX2018000166A (pl)
PL (1) PL3325080T3 (pl)
RU (1) RU2719943C2 (pl)
WO (1) WO2017019526A2 (pl)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2991455C (en) * 2015-07-24 2023-10-10 Kimberly-Clark Worldwide, Inc. Methods for better delivery of active agents to tumors
PL3325081T3 (pl) * 2015-07-24 2021-12-20 Sorrento Therapeutics, Inc. Sposoby dostarczania limfatycznego środków czynnych
US11541015B2 (en) 2017-05-17 2023-01-03 Massachusetts Institute Of Technology Self-righting systems, methods, and related components
CA3063711A1 (en) 2017-05-17 2018-11-22 Massachusetts Institute Of Technology Self-righting systems, methods, and related components
EP3652133A4 (en) 2017-07-10 2021-04-21 Basf Se MIXTURES WITH A UREA INHIBITOR (UI) AND A NITRIFICATION INHIBITOR SUCH AS 2- (3,4-DIMETHYL-1H-PYRAZOL-1-YL) SUCCIC ACID (DMPSA) OR 3,4-DIMETHYLPYRAZOLYL GLYCOLATE (DMPG)
EP3793667A1 (en) 2018-05-17 2021-03-24 Massachusetts Institute of Technology Systems for electrical stimulation
MX2020012789A (es) * 2018-05-31 2021-04-28 Sorrento Therapeutics Inc Métodos de suministro de fármacos dirigidos al sistema linfático.
EP3856322A1 (en) 2018-09-24 2021-08-04 L'oreal Device comprising microneedles for in-situ reaction of a skin
WO2020064082A1 (en) * 2018-09-24 2020-04-02 L'oreal Device comprising microneedles for skin-coloring
KR20220110273A (ko) * 2019-12-05 2022-08-05 소렌토 쎄라퓨틱스, 인코포레이티드 항-pd-1 또는 항-pd-l1 치료제를 림프 전달 장치를 통해 투여하여 암을 치료하는 방법
CN117813128A (zh) 2021-01-22 2024-04-02 索伦托药业有限公司 用于微升级淋巴递送冠状病毒疫苗的装置
WO2022192594A2 (en) 2021-03-11 2022-09-15 Sorrento Therapeutics, Inc. Nucleic acid molecules and vaccines comprising same for the prevention and treatment of coronavirus infections and disease
CA3221925A1 (en) 2021-06-09 2022-12-15 Sorrento Therapeutics, Inc. Method of treating cancer by administration of an anti-pd-1 or anti-pd-l1 therapeutic agent via a lymphatic microneedle delivery device
JP2024531337A (ja) 2021-08-18 2024-08-29 ソレント・セラピューティクス・インコーポレイテッド リンパ系を標的化する治療剤
WO2025129128A1 (en) 2023-12-15 2025-06-19 Vivasor, Inc. Compositions and methods for non-viral delivery of therapeutic compounds

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE72524B1 (en) 1994-11-04 1997-04-23 Elan Med Tech Analyte-controlled liquid delivery device and analyte monitor
AU785199B2 (en) 2000-06-01 2006-11-02 Watson Pharmaceuticals, Inc. Transdermal delivery of lasofoxifene
EP1432466B1 (en) * 2001-09-12 2012-08-15 Becton, Dickinson and Company Microneedle-based pen device for drug delivery and method for using same
EP1635876A4 (en) 2003-06-13 2009-05-06 Becton Dickinson Co IMPROVED INTRADERMAL ADMINISTRATION OF BIOACTIVE AGENTS
US20050180952A1 (en) 2003-08-26 2005-08-18 Pettis Ronald J. Methods for intradermal delivery of therapeutics agents
US20070191815A1 (en) * 2004-09-13 2007-08-16 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery
US20070088414A1 (en) * 2005-05-25 2007-04-19 Campbell Robert L Particulate formulations for intradermal delivery of biologically active agents
WO2006138719A2 (en) * 2005-06-17 2006-12-28 Georgia Tech Research Corporation Coated microstructures and method of manufacture thereof
US8197435B2 (en) 2006-05-02 2012-06-12 Emory University Methods and devices for drug delivery to ocular tissue using microneedle
EP2100850A1 (en) * 2008-03-11 2009-09-16 Stichting Voor De Technische Wetenschappen Microneedle array and a method for manufacturing microneedles
US8715736B2 (en) * 2009-04-30 2014-05-06 Florida Agricultural And Mechanical University Nanoparticle formulations for skin delivery
CN101829394B (zh) * 2010-04-27 2012-08-22 上海交通大学 台阶微针阵列的制备方法
KR20130058012A (ko) 2010-04-28 2013-06-03 킴벌리-클라크 월드와이드, 인크. 사출 성형된 마이크로니들 어레이 및 마이크로니들 어레이의 형성 방법
WO2011135531A2 (en) 2010-04-28 2011-11-03 Kimberly-Clark Worldwide, Inc. MEDICAL DEVICES FOR DELIVERY OF siRNA
MX345837B (es) 2010-04-28 2017-02-16 Kimberly-Clark Worldwide Incorporated Dispositivo para la entrega de un medicamento para la artritis reumatoide.
EP2563455A4 (en) 2010-04-28 2014-02-19 Kimberly Clark Co METHOD FOR INCREASING THE PERMEABILITY OF AN EPITHELIAL BARRIER
US20120187814A1 (en) 2011-01-25 2012-07-26 Fryling Nicholas A Furniture System and a Frame Assembly for a Furniture System
US20120245445A1 (en) * 2011-03-21 2012-09-27 Michael Darryl Black Glucose Monitoring System
ES2764105T3 (es) * 2011-10-17 2020-06-02 Massachusetts Inst Technology Administración intracelular
MX343262B (es) * 2011-10-27 2016-10-28 Kimberly Clark Co Administración transdérmica de agentes bioactivos de alta viscosidad.
KR101575039B1 (ko) 2012-07-19 2015-12-07 (주)아모레퍼시픽 노즐 장치 및 이를 포함하는 최소 침습형 주입 장치
BR112015005073B1 (pt) * 2012-09-13 2021-06-01 Amir Avraham Aplicador configurado para a administração de uma composição de melhoria de pele para uma pele e/ou subcútis de um sujeito, uso de um, microagulha e método para manufaturar uma microagulha
PT2897620T (pt) * 2012-09-21 2020-09-03 Intensity Therapeutics Inc Método de tratamento de cancro
CN103157178B (zh) * 2013-02-05 2014-12-31 北京化工大学 精确控制微针插入长度的印章式工具
EP2961471B1 (en) 2013-02-28 2023-10-25 Sorrento Therapeutics, Inc. Transdermal drug delivery device
WO2014132239A1 (en) 2013-02-28 2014-09-04 Kimberly-Clark Worldwide, Inc. Drug delivery device
BR112015027608A2 (pt) 2013-05-23 2017-07-25 Kimberly Clark Co microagulhas com geometrias transversais de canal aberto melhoradas
US10376674B2 (en) * 2014-09-15 2019-08-13 Ethicon, Inc. System and method for targeted delivery of therapeutic agents to tissue
CA2991455C (en) * 2015-07-24 2023-10-10 Kimberly-Clark Worldwide, Inc. Methods for better delivery of active agents to tumors
PL3325081T3 (pl) * 2015-07-24 2021-12-20 Sorrento Therapeutics, Inc. Sposoby dostarczania limfatycznego środków czynnych

Also Published As

Publication number Publication date
MX2018000166A (es) 2018-03-26
US20210052871A1 (en) 2021-02-25
EP3325080B1 (en) 2021-09-01
ES2891523T3 (es) 2022-01-28
AU2016297823B2 (en) 2020-10-22
US20240238570A1 (en) 2024-07-18
US20180193624A1 (en) 2018-07-12
AU2021200146B2 (en) 2022-08-25
AU2021200146A1 (en) 2021-03-18
CN118902979A (zh) 2024-11-08
RU2018104102A3 (pl) 2019-11-06
RU2018104102A (ru) 2019-08-27
KR20180035209A (ko) 2018-04-05
WO2017019526A2 (en) 2017-02-02
CA2991455A1 (en) 2017-02-02
EP3325080A4 (en) 2019-04-17
AU2016297823A1 (en) 2018-02-15
EP3925599A1 (en) 2021-12-22
EP3325080A2 (en) 2018-05-30
JP2018521755A (ja) 2018-08-09
RU2719943C2 (ru) 2020-04-23
AU2022275397A1 (en) 2023-01-05
DK3325080T3 (da) 2021-10-04
HUE056410T2 (hu) 2022-02-28
BR112018001292A2 (pt) 2018-09-11
JP7082041B2 (ja) 2022-06-07
CN107921248A (zh) 2018-04-17
US10806913B2 (en) 2020-10-20
CA2991455C (en) 2023-10-10
MX2022014277A (es) 2022-12-07

Similar Documents

Publication Publication Date Title
CY2024035I2 (el) Συνθεσεις αντισωματων για τη θεραπεια ογκων
FR21C1059I1 (fr) Compositions pharmaceutiques
IL264901B (en) Administration of kynurenine depleting enzymes for tumor therapy
SI3350157T1 (sl) Sestave za doziranje terapevtskih sredstev v celice
AU2016297823B2 (en) Methods for better delivery of active agents to tumors
PL3377516T3 (pl) Kompozycja do leczenia nowotworu
HUE047477T2 (hu) Palbociclib szilárd dózisformái
ZA201506916B (en) Microstructure array for delivery of active agents
PL3283527T3 (pl) Leczenie skojarzone nowotworów
HRP20181679T1 (hr) Amidni spojevi za liječenje hiv
PL3297605T3 (pl) Kompozycje farmaceutyczne do stosowania miejscowego
DK3107563T3 (da) Glycomålrettede terapeutiske midler
LT2968221T (lt) S-ketamino hidrochlorido farmacinė kompozicija
DK3234107T3 (da) B-celler til in vivo-levering af terapeutiske midler
PL3310904T3 (pl) Komórkowy układ ukierunkowanego dostarczania substancji czynnej
LT2981255T (lt) Empagliflozino terapiniai panaudojimo būdai
KR102494289B9 (ko) 활성 혼합물
LT3116491T (lt) Terapiškai aktyvių junginių farmacinės kompozicijos
PL3186244T3 (pl) Analogi dioksolanowe urydyny w leczeniu raka
HRP20190101T1 (hr) Terapeutske uporabe empagliflozina
MA39483A (fr) Agents thérapeutiques cibles
SI4119569T1 (sl) Konjugirane protismiselne spojine za uporabo v terapiji
PL3325081T3 (pl) Sposoby dostarczania limfatycznego środków czynnych
IL256206A (en) Mct4 inhibitors for treating disease
DK3363428T3 (da) Perfusionsdoseringsform